

Cover Story
Free
Real world data played a role in FDA's recent decision to expand the indications for Pfizer's drug Ibrance (palbociclib) to include men.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Betty Ford and the press conference that changed oncology
- ARPA-H placed outside NIH in authorization bill approved in a 336-85 House vote
- Dave Boule confronted polycythemia vera with an accountant’s consistency
- NCI strategy for evaluating MCED assays may bypass cancer clinical trials groups
- Lucius Sinks, a giant in pediatric cancer, dies at 91
“We were able to come together at Roswell Park and help the kids.” - Alex A. Adjei named chair of Cleveland Clinic Taussig Cancer Institute